Q92733 (PRCC_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 100.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Proline-rich protein PRCC Alternative name(s): Papillary renal cell carcinoma translocation-associated gene protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 491 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May regulate cell cycle progression through interaction with MAD2L2. Ref.7 |
| Subunit structure | Interacts with MAD2L2; the interaction is direct. Ref.7 |
| Subcellular location | |
| Tissue specificity | Ubiquitous in fetal and adult tissues. |
| Involvement in disease | Note=A chromosomal aberration involving PRCC is found in patients with papillary renal cell carcinoma. Translocation t(X;1)(p11.2;q21.2) with TFE3. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Cell cycle |
| Cellular component | Nucleus |
| Coding sequence diversity | Chromosomal rearrangement Polymorphism |
| Disease | Proto-oncogene |
| PTM | Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | cell cycle Inferred from electronic annotation. Source: UniProtKB-KW mitotic cell cycle checkpointInferred from direct assay Ref.7. Source: UniProtKB |
| Cellular component | nucleus Inferred from direct assay Ref.7. Source: UniProtKB |
| Molecular function | protein binding Inferred from physical interaction Ref.7. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 491 | 491 | Proline-rich protein PRCC | PRO_0000058568 | |||||
Regions | |||||||||
| Region | 1 – 100 | 100 | Mediates interaction with MAD2L2 | ||||||
| Compositional bias | 18 – 25 | 8 | Poly-Glu | ||||||
| Compositional bias | 52 – 55 | 4 | Poly-Pro | ||||||
| Compositional bias | 79 – 84 | 6 | Poly-Pro | ||||||
| Compositional bias | 91 – 94 | 4 | Poly-Pro | ||||||
| Compositional bias | 235 – 239 | 5 | Poly-Thr | ||||||
Amino acid modifications | |||||||||
| Modified residue | 8 | 1 | Phosphoserine Ref.8 | ||||||
| Modified residue | 9 | 1 | Phosphoserine Ref.8 | ||||||
| Modified residue | 12 | 1 | Phosphoserine Ref.8 | ||||||
| Modified residue | 157 | 1 | Phosphoserine Ref.8 Ref.9 Ref.10 Ref.12 | ||||||
| Modified residue | 159 | 1 | Phosphoserine Ref.8 Ref.9 Ref.10 Ref.12 | ||||||
| Modified residue | 218 | 1 | Phosphoserine Ref.8 | ||||||
| Modified residue | 239 | 1 | Phosphothreonine Ref.11 | ||||||
| Modified residue | 241 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 243 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 267 | 1 | Phosphoserine Ref.10 Ref.11 | ||||||
Natural variations | |||||||||
| Natural variant | 136 | 1 | P → S. Ref.3 Corresponds to variant rs11264542 [ dbSNP | Ensembl ]. | VAR_024341 | |||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene." Sidhar S.K., Clark J., Gill S., Hamoudi R., Crew A.J., Gwilliam R., Ross M., Linehan W.M., Birdsall S., Shipley J., Cooper C.S. Hum. Mol. Genet. 5:1333-1338(1996) [PubMed: 8872474] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], CHROMOSOMAL TRANSLOCATION WITH TFE3. Tissue: Monocyte. |
| [2] | "Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas." Weterman M.A.J., Wilbrink M., Geurts van Kessel A. Proc. Natl. Acad. Sci. U.S.A. 93:15294-15298(1996) [PubMed: 8986805] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], CHROMOSOMAL TRANSLOCATION WITH TFE3. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT SER-136. Tissue: Caudate nucleus. |
| [4] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [7] | "Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas." Weterman M.A., van Groningen J.J., Tertoolen L., van Kessel A.G. Proc. Natl. Acad. Sci. U.S.A. 98:13808-13813(2001) [PubMed: 11717438] [Abstract] Cited for: FUNCTION, INTERACTION WITH MAD2L2, SUBCELLULAR LOCATION. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8; SER-9; SER-12; SER-157; SER-159 AND SER-218, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157 AND SER-159, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [10] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-159 AND SER-267, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-239; SER-241; SER-243 AND SER-267, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [12] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157 AND SER-159, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [13] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | X97124 mRNA. Translation: CAA65791.1. X99720 Genomic DNA. Translation: CAA68060.1. AK289872 mRNA. Translation: BAF82561.1. AL590666 Genomic DNA. Translation: CAI16350.1. CH471121 Genomic DNA. Translation: EAW52909.1. BC004913 mRNA. Translation: AAH04913.1. |
| IPI | IPI00294618. |
| RefSeq | NP_005964.3. NM_005973.4. |
| UniGene | Hs.516948. |
3D structure databases | |
| ProteinModelPortal | Q92733. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q92733. 1 interaction. |
| MINT | MINT-4536336. |
| STRING | Q92733. |
PTM databases | |
| PhosphoSite | Q92733. |
Polymorphism databases | |
| DMDM | 2498802. |
Proteomic databases | |
| PRIDE | Q92733. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000271526; ENSP00000271526; ENSG00000143294. |
| GeneID | 5546. |
| KEGG | hsa:5546. |
| UCSC | uc001fqa.1. human. |
Organism-specific databases | |
| CTD | 5546. |
| GeneCards | GC01P156720. |
| H-InvDB | HIX0001176. |
| HGNC | HGNC:9343. PRCC. |
| HPA | CAB017151. HPA019463. HPA019481. |
| MIM | 179755. gene. |
| neXtProt | NX_Q92733. |
| Orphanet | 47044. Familial papillary renal cell carcinoma. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG14677. |
| HOGENOM | HBG714870. |
| HOVERGEN | HBG002845. |
| InParanoid | Q92733. |
| OMA | APKTKPS. |
| OrthoDB | EOG4MSCZR. |
| PhylomeDB | Q92733. |
Gene expression databases | |
| ArrayExpress | Q92733. |
| Bgee | Q92733. |
| CleanEx | HS_PRCC. |
| Genevestigator | Q92733. |
| GermOnline | ENSG00000143294. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR018800. PRCC_C. [Graphical view] |
| KO | K13105. |
| Pfam | PF10253. PRCC_Cterm. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 21488. |
| SOURCE | Search... |
Entry information
| Entry name | PRCC_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q92733 Secondary accession number(s): A8K1F7 Q5SZ06 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |

Clusters with